235 purchase as supplier for a total of 1.7 millones (1,695,026.493 ) between 2012 and 2014.
Overcost in MXN
1.1 millones pesos mexicanos (1,120,893.054 MXN)
Overcost in %
351.5 %
| Product | Purchases | Total amount | Overcost in MXN | Overcost in % | Period |
|---|---|---|---|---|---|
| AZATIOPRINA | 16 | 274,422.7 MXN | 190,048.3 MXN | 534.4 % | 2012 - 2013 |
| DIDANOSINA | 16 | 184,658.4 MXN | 114,825.8 MXN | 157.8 % | 2013 - 2013 |
| HEMOSTÁTICOS | 9 | 83,525.8 MXN | 52,490.8 MXN | 170.6 % | 2013 - 2013 |
| CILOSTAZOL | 7 | 19,034 MXN | 7,518.2 MXN | 57.1 % | 2013 - 2014 |
| ATORVASTATINA | 7 | 73,447.3 MXN | 62,721.1 MXN | 642.6 % | 2013 - 2014 |
| PANTOPRAZOL O RABEPRAZOL U OMEPRAZOL | 7 | 70,884.5 MXN | 46,610.7 MXN | 203 % | 2013 - 2013 |
| FELODIPINO | 6 | 4,350 MXN | 2,503.5 MXN | 135.6 % | 2013 - 2013 |
| SUTURAS | 6 | 47,519 MXN | 35,245.1 MXN | 275.4 % | 2013 - 2013 |
| PREDNISONA | 5 | 38,503.2 MXN | 35,936.4 MXN | 1,982.8 % | 2013 - 2013 |
| RANITIDINA | 4 | 52,911.4 MXN | 31,923.8 MXN | 170.7 % | 2012 - 2013 |
1 contract as supplier for a total of 581.9 between 2011 and 2011.
Country
Identifiers
RFC: RARG690405SK5
Date updated in QQW
9 de mayo de 2021
Part of the project
Organization responsible for the import